>>Signaling Pathways>> Chromatin/Epigenetics>> Histone Acetyltransferases>>NiCur

NiCur

Catalog No.GC62248

NiCur는 0.35μM의 IC50 값을 갖는 강력하고 선택적인 CBP 히스톤 아세틸트랜스퍼라제(HAT) 억제제입니다. CBP HAT 활성을 차단하고 유전독성 스트레스 시 p53 활성화를 하향 조절하는 NiCur. NiCur는 표적 단백질의 발현에 영향을 미치지 않고 기계론적 연구를 수행하는 데 사용할 수 있습니다.

Products are for research use only. Not for human use. We do not sell to patients.

NiCur Chemical Structure

Size 가격 재고 수량
5 mg
US$180.00
재고 있음
10 mg
US$315.00
재고 있음
25 mg
US$585.00
재고 있음
50 mg
US$855.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

NiCur is a potent and selective CBP histone acetyltransferase (HAT) inhibitor with an IC50 value of 0.35 μμ. NiCur, which blocks CBP HAT activity and downregulates p53 activation upon genotoxic stress. NiCur can be used for performing mechanistic studies without affecting the expression of target proteins[1].

NiCur (0.5~1 μM; U2OS cells) reduces the Dox-induced p53K382ac, p53S15p, and p53 levels in a dose-dependent manner[1].NiCur (1.5 μM) reduces the level of H3K27ac. NiCur (1.5 μM; U2OS cells) restores cellular proliferation. NiCur (Intestinal epithelial cells) down-regulates Dox-mediated p53 activation without affecting the levels of H2A.X S139p. NiCur can modulate the gene regulatory switch for reprogramming chromatin landscape. NiCur blocks CBP HAT activity[1].

[1]. Vincek AS, et al. Inhibitor of CBP Histone Acetyltransferase Downregulates p53 Activation and Facilitates Methylation at Lysine 27 on Histone H3. Molecules. 2018;23(8):1930. Published 2018 Aug 2.

리뷰

Review for NiCur

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for NiCur

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.